OBSERVE: Biomarkers in Individuals at Risk for Prion Disease

Recruiting Observational Study
CJD (Creutzfeldt Jakob Disease) Prion Diseases GSS FFI Familial Fatal Insomnia
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 85
Sex
Any
Study type
Observational
Participants needed
150 (estimated)
Sponsor
Massachusetts General Hospital · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

We are doing this research to identify biomarkers in individuals who are at-risk for familial prion disease. We hope to use these biomarkers to predict timing of disease onset in pre-symptomatic individuals and to guide the direction of future clinical trials.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: 1. Aged 18 - 85, 2. One of the following: * a. Known carrier of pathogenic PRNP mutation * b. History of probable or definite prion disease in biological parent and other family members * c. Non-carrier family members and/or unrelated previously enrolled negative contr…
Contacts

Sophia D'Alessandro

617-726-4026

MGHPrionStudy@partners.org

CONTACT

Alison McManus, DNP

ajmcmanus@mgh.harvard.edu

CONTACT